BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24469030)

  • 1. Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.
    Nagel D; Vincendeau M; Eitelhuber AC; Krappmann D
    Oncogene; 2014 Dec; 33(50):5655-65. PubMed ID: 24469030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma.
    Ang DA; Carter JM; Deka K; Tan JHL; Zhou J; Chen Q; Chng WJ; Harmston N; Li Y
    Nat Commun; 2024 Mar; 15(1):2513. PubMed ID: 38514625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
    Bargou RC; Emmerich F; Krappmann D; Bommert K; Mapara MY; Arnold W; Royer HD; Grinstein E; Greiner A; Scheidereit C; Dörken B
    J Clin Invest; 1997 Dec; 100(12):2961-9. PubMed ID: 9399941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.
    Yu L; Li L; Medeiros LJ; Young KH
    Blood Rev; 2017 Mar; 31(2):77-92. PubMed ID: 27773462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.
    Nakshatri H; Bhat-Nakshatri P; Martin DA; Goulet RJ; Sledge GW
    Mol Cell Biol; 1997 Jul; 17(7):3629-39. PubMed ID: 9199297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells.
    van Keimpema M; Grüneberg LJ; Mokry M; van Boxtel R; Koster J; Coffer PJ; Pals ST; Spaargaren M
    Blood; 2014 Nov; 124(23):3431-40. PubMed ID: 25267198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB in cellular senescence and cancer treatment.
    Jing H; Lee S
    Mol Cells; 2014 Mar; 37(3):189-95. PubMed ID: 24608805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell receptor signaling in diffuse large B-cell lymphoma.
    Young RM; Shaffer AL; Phelan JD; Staudt LM
    Semin Hematol; 2015 Apr; 52(2):77-85. PubMed ID: 25805587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.
    Braggio E; Van Wier S; Ojha J; McPhail E; Asmann YW; Egan J; da Silva JA; Schiff D; Lopes MB; Decker PA; Valdez R; Tibes R; Eckloff B; Witzig TE; Stewart AK; Fonseca R; O'Neill BP
    Clin Cancer Res; 2015 Sep; 21(17):3986-94. PubMed ID: 25991819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
    Clipson A; Wang M; de Leval L; Ashton-Key M; Wotherspoon A; Vassiliou G; Bolli N; Grove C; Moody S; Escudero-Ibarz L; Gundem G; Brugger K; Xue X; Mi E; Bench A; Scott M; Liu H; Follows G; Robles EF; Martinez-Climent JA; Oscier D; Watkins AJ; Du MQ
    Leukemia; 2015 May; 29(5):1177-85. PubMed ID: 25428260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy.
    Carbone A; Gloghini A; Kwong YL; Younes A
    Ann Hematol; 2014 Aug; 93(8):1263-77. PubMed ID: 24870942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma.
    Roccaro AM; Sacco A; Jimenez C; Maiso P; Moschetta M; Mishima Y; Aljawai Y; Sahin I; Kuhne M; Cardarelli P; Cohen L; San Miguel JF; Garcia-Sanz R; Ghobrial IM
    Blood; 2014 Jun; 123(26):4120-31. PubMed ID: 24711662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB deregulation in Hodgkin lymphoma.
    Weniger MA; Küppers R
    Semin Cancer Biol; 2016 Aug; 39():32-9. PubMed ID: 27221964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
    Chapuy B; Stewart C; Dunford AJ; Kim J; Kamburov A; Redd RA; Lawrence MS; Roemer MGM; Li AJ; Ziepert M; Staiger AM; Wala JA; Ducar MD; Leshchiner I; Rheinbay E; Taylor-Weiner A; Coughlin CA; Hess JM; Pedamallu CS; Livitz D; Rosebrock D; Rosenberg M; Tracy AA; Horn H; van Hummelen P; Feldman AL; Link BK; Novak AJ; Cerhan JR; Habermann TM; Siebert R; Rosenwald A; Thorner AR; Meyerson ML; Golub TR; Beroukhim R; Wulf GG; Ott G; Rodig SJ; Monti S; Neuberg DS; Loeffler M; Pfreundschuh M; Trümper L; Getz G; Shipp MA
    Nat Med; 2018 May; 24(5):679-690. PubMed ID: 29713087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report.
    Asrani R; Cengiz TB; Petersen BE; Anagnostou T; Brody JD
    Front Oncol; 2023; 13():1254256. PubMed ID: 38313213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of α-pinene in T-cell tumors.
    Abe M; Asada N; Kimura M; Fukui C; Yamada D; Wang Z; Miyake M; Takarada T; Ono M; Aoe M; Kitamura W; Matsuda M; Moriyama T; Matsumura A; Maeda Y
    Cancer Sci; 2024 Apr; 115(4):1317-1332. PubMed ID: 38279512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Alterations of NF-κB and Its Regulators: A Rich Platform to Advance Colorectal Cancer Diagnosis and Treatment.
    Alipourgivi F; Motolani A; Qiu AY; Qiang W; Yang GY; Chen S; Lu T
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas.
    Wimberger N; Ober F; Avar G; Grau M; Xu W; Lenz G; Menden MP; Krappmann D
    Blood; 2023 Dec; 142(23):1985-2001. PubMed ID: 37623434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Quantitative Computed Tomography-Based Analysis of Abdominal Adipose Tissue in Patients with Lymphoma.
    Greco F; Beomonte Zobel B; Mallio CA
    Hematol Rep; 2023 Aug; 15(3):474-482. PubMed ID: 37606494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of the P2X7 receptor in the proliferation of human diffused large B-cell lymphoma.
    Yang X; Ji Y; Mei L; Jing W; Yang X; Liu Q
    Purinergic Signal; 2023 May; ():. PubMed ID: 37222921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.